id int64 0 27.3k | prompt listlengths 1 1 | completion listlengths 1 1 | Label stringclasses 4 values |
|---|---|---|---|
0 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: The prevalence of obesity in children is reaching epidemic proportions. Excess adiposity is more than just a cosmetic problem, having substantial metabolic co... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
1 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Correction of Myopia Evaluation Trial (COMET)\nBrief Summary: To evaluate whether progressive addition lenses (PALs) slow the rate of progression of juvenile-onset myopia (nearsi... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
2 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Correction of Myopia Evaluation Trial (COMET)\nBrief Summary: To evaluate whether progressive addition lenses (PALs) slow the rate of progression of juvenile-onset myopia (nearsi... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
3 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To evaluate the relative efficacy of orthokeratology, primarily by assessment of changes in central corneal thickness, astigmatism, visual acuity, endothelial... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
4 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To test the hypothesis that correction with bifocal spectacle lenses rather than single-vision lenses will slow the progression of myopia in children with nea... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
5 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Submacular Surgery Trials (SST)\nBrief Summary: To determine whether surgical removal of subfoveal choroidal neovascularization (CNV) and associated hemorrhage in patients with a... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
6 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Submacular Surgery Trials (SST)\nBrief Summary: To determine whether surgical removal of subfoveal choroidal neovascularization (CNV) and associated hemorrhage in patients with a... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
7 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Submacular Surgery Trials (SST)\nBrief Summary: To determine whether surgical removal of subfoveal choroidal neovascularization (CNV) and associated hemorrhage in patients with a... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
8 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To determine whether 50 mg of beta-carotene taken every other day reduces the risk of developing age-related macular degeneration (AMD) among male U.S. physic... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
9 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Amblyopia Treatment Study: Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia\nBrief Summary: * To determine whether the success rate with drug treatment (atropine) of... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
10 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Amblyopia Treatment Study: Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia\nBrief Summary: * To determine whether the success rate with drug treatment (atropine) of... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
11 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Amblyopia Treatment Study: Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia\nBrief Summary: * To determine whether the success rate with drug treatment (atropine) of... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
12 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Amblyopia Treatment Study: Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia\nBrief Summary: * To determine whether the success rate with drug treatment (atropine) of... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
13 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: This protocol is a multicenter clinical trial of melatonin for sleep disturbances associated with Alzheimer's disease (AD). Frequent nocturnal awakening is a ... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
14 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: The purpose of this study is to design a program to prevent suicide in elderly patients by educating patients, their families, and physicians on depression an... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
15 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: The purpose of this study is to design a program to prevent suicide in elderly patients by educating patients, their families, and physicians on depression an... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
16 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Multimodal Treatment Study of Children With ADHD\nBrief Summary: This trial is a continuation of the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity D... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
17 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Multimodal Treatment Study of Children With ADHD\nBrief Summary: This trial is a continuation of the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity D... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
18 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Multimodal Treatment Study of Children With ADHD\nBrief Summary: This trial is a continuation of the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity D... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
19 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Multimodal Treatment Study of Children With ADHD\nBrief Summary: This trial is a continuation of the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity D... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
20 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Multimodal Treatment Study of Children With ADHD\nBrief Summary: This trial is a continuation of the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity D... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
21 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Spine Patient Outcomes Research Trial (SPORT): A Multicenter Randomized Trial for Degenerative Spondylolisthesis (DS) With Spinal Stenosis (SpS) at L4/L5 Level.\nBrief Summary: T... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
22 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Spine Patient Outcomes Research Trial (SPORT): A Multicenter Randomized Trial for Degenerative Spondylolisthesis (DS) With Spinal Stenosis (SpS) at L4/L5 Level.\nBrief Summary: T... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
23 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Spine Patient Outcomes Research Trial (SPORT): A Multicenter Trial for Spinal Stenosis (SpS)\nBrief Summary: This study tests the effectiveness of different treatments for the th... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
24 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Spine Patient Outcomes Research Trial (SPORT): A Multicenter Trial for Spinal Stenosis (SpS)\nBrief Summary: This study tests the effectiveness of different treatments for the th... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
25 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Self-Efficacy and High-Intensity Strength Training to Improve Postoperative Rehabilitation of Hip Fracture Patients\nBrief Summary: This project will assess the effectiveness of ... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
26 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Pharmacologic Relapse Prevention for Alcoholic Smokers\nBrief Summary: This study will compare the long-term use of bupropion (Wellbutrin) and placebo for reducing the rate of sm... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
27 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Pharmacologic Relapse Prevention for Alcoholic Smokers\nBrief Summary: This study will compare the long-term use of bupropion (Wellbutrin) and placebo for reducing the rate of sm... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
28 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Pharmacologic Relapse Prevention for Alcoholic Smokers\nBrief Summary: This study will compare the long-term use of bupropion (Wellbutrin) and placebo for reducing the rate of sm... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
29 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Pharmacologic Relapse Prevention for Alcoholic Smokers\nBrief Summary: This study will compare the long-term use of bupropion (Wellbutrin) and placebo for reducing the rate of sm... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
30 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Pharmacologic Relapse Prevention for Alcoholic Smokers\nBrief Summary: This study will compare the long-term use of bupropion (Wellbutrin) and placebo for reducing the rate of sm... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
31 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To determine whether warfarin or lovastatin alone or in combination retarded the progression of atherosclerotic plaques in the carotid arteries of high risk i... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
32 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To determine whether warfarin or lovastatin alone or in combination retarded the progression of atherosclerotic plaques in the carotid arteries of high risk i... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
33 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To determine whether warfarin or lovastatin alone or in combination retarded the progression of atherosclerotic plaques in the carotid arteries of high risk i... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
34 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Women's Health Study of Low-dose Aspirin and Vitamin E in Apparently Healthy Women\nBrief Summary: The purpose of this study is to evaluate the effects of low-dose aspirin and vi... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
35 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Women's Health Study of Low-dose Aspirin and Vitamin E in Apparently Healthy Women\nBrief Summary: The purpose of this study is to evaluate the effects of low-dose aspirin and vi... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
36 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Women's Health Study of Low-dose Aspirin and Vitamin E in Apparently Healthy Women\nBrief Summary: The purpose of this study is to evaluate the effects of low-dose aspirin and vi... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
37 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Women's Health Study of Low-dose Aspirin and Vitamin E in Apparently Healthy Women\nBrief Summary: The purpose of this study is to evaluate the effects of low-dose aspirin and vi... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
38 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Women's Health Study of Low-dose Aspirin and Vitamin E in Apparently Healthy Women\nBrief Summary: The purpose of this study is to evaluate the effects of low-dose aspirin and vi... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
39 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To evaluate the feasibility of recruiting women of different socioeconomic status and minority groups and to determine whether these women could achieve and m... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
40 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: The primary objective was to assess whether long-term administration of antihypertensive therapy to elderly subjects with isolated systolic hypertension reduc... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
41 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: The primary objective was to assess whether long-term administration of antihypertensive therapy to elderly subjects with isolated systolic hypertension reduc... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
42 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: The primary objective was to assess whether long-term administration of antihypertensive therapy to elderly subjects with isolated systolic hypertension reduc... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
43 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)\nBrief Summary: To determine if supplements of vitamin C, vitamin E, beta-carotene, and B-vitamins (a combination... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
44 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)\nBrief Summary: To determine if supplements of vitamin C, vitamin E, beta-carotene, and B-vitamins (a combination... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
45 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)\nBrief Summary: To determine if supplements of vitamin C, vitamin E, beta-carotene, and B-vitamins (a combination... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
46 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)\nBrief Summary: To determine if supplements of vitamin C, vitamin E, beta-carotene, and B-vitamins (a combination... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
47 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)\nBrief Summary: To determine if supplements of vitamin C, vitamin E, beta-carotene, and B-vitamins (a combination... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
48 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)\nBrief Summary: To determine if supplements of vitamin C, vitamin E, beta-carotene, and B-vitamins (a combination... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
49 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To determine if the combined incidence of nonfatal myocardial infarction and coronary heart disease death differs between diuretic-based and each of three alt... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
50 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To determine if the combined incidence of nonfatal myocardial infarction and coronary heart disease death differs between diuretic-based and each of three alt... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
51 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To determine if the combined incidence of nonfatal myocardial infarction and coronary heart disease death differs between diuretic-based and each of three alt... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
52 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To determine if the combined incidence of nonfatal myocardial infarction and coronary heart disease death differs between diuretic-based and each of three alt... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
53 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To determine if the combined incidence of nonfatal myocardial infarction and coronary heart disease death differs between diuretic-based and each of three alt... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
54 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To test the hypothesis that low-dose inhaled nitric oxide administered to preterm infants who continue to require mechanical ventilation at 14 days of age wil... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
55 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To test if early revascularization, primarily with angioplasty (PTCA) or bypass surgery (CABG), reduced all-cause in-hospital mortality from cardiogenic shock... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
56 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To determine whether the addition of angiotensin converting enzyme (ACE) inhibitor to standard therapy in patients with known coronary artery disease and pres... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
57 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To determine the effects, in postmenopausal women, of hormone replacement therapy on progression/regression of coronary heart disease, as measured by quantita... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
58 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To determine the effects, in postmenopausal women, of hormone replacement therapy on progression/regression of coronary heart disease, as measured by quantita... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
59 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Childhood Asthma Management Program\nBrief Summary: The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
60 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Childhood Asthma Management Program\nBrief Summary: The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
61 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Childhood Asthma Management Program\nBrief Summary: The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
62 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: Childhood Asthma Management Program\nBrief Summary: The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
63 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To reduce episodes of first time stroke by 75 percent in children with sickle cell anemia by the administration of prophylactic transfusion therapy.\n\n\n**Op... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
64 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To reduce episodes of first time stroke by 75 percent in children with sickle cell anemia by the administration of prophylactic transfusion therapy.\n\n\n**Op... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
65 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To reduce episodes of first time stroke by 75 percent in children with sickle cell anemia by the administration of prophylactic transfusion therapy.\n\n\n**Op... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
66 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To reduce episodes of first time stroke by 75 percent in children with sickle cell anemia by the administration of prophylactic transfusion therapy.\n\n\n**Op... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
67 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To evaluate the long term efficacy, morbidity and mortality associated with medical therapy with lung volume reduction surgery (LVRS) as compared to medical t... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
68 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To evaluate the long term efficacy, morbidity and mortality associated with medical therapy with lung volume reduction surgery (LVRS) as compared to medical t... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
69 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To compare conventional treatment of congestive heart failure (CHF) with two experimental interventions: amiodarone and an implantable cardioverter-defibrilla... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
70 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
71 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
72 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
73 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
74 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
75 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
76 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
77 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
78 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
79 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
80 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
81 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
82 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
83 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
84 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
85 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
86 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
87 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
88 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
89 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
90 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
91 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
92 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** D\n"
}
] | D |
93 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** B\n"
}
] | B |
94 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
95 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
96 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
97 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
98 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** A\n"
}
] | A |
99 | [
{
"role": "user",
"content": "Please select the arm or intervention descriptions that belong to the clinical trial below.\nTitle: N/A\nBrief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women... | [
{
"role": "assistant",
"content": "**Answer:** C\n"
}
] | C |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.